Among the patients classified as GPA by the EMA algorithm, 71.4% were not classified as GPA under the 2022 ACR/EULAR criteria due to negative results for PR3-ANCA (or c-ANCA). This evidence concerns the gene PRTN3 and granulomatosis with polyangiitis.